Plasma-based NGS identifies clinically relevant genomic alterations in metastatic lung adenocarcinoma and complementstissue-based molecular testing in routine practice in a real-world setting.
E. Kocaaslan, Emir Göçer, Fırat Akagündüz et al.· Marmara Medical Journal· 0 citations
Background and Objectives: This study aimed to validate the prognostic value of clinicopathologic risk factors and assess the discriminatory performance of a guideline-based seven-factor risk stratification system in T3N0 colon cancer. Secondary objectives included examining the independent prognostic role of mucinous...
A. Çelebi, Eren Meral, Fırat Akagündüz et al.· Medicina· 0 citations
Capecitabine is an oral fluoropyrimidine prodrug widely used in the treatment of various malignancies, including colorectal cancer. While it is generally well-tolerated, rare and life-threatening toxicities can occur. Pneumonitis is an exceedingly rare complication associated with capecitabine monotherapy. A 36-year-ol...
M. A. Tunç, A. Güren, B. Paçacı et al.· Anti-Cancer Drugs· 0 citations
Background/Objectives: The prognostic nutritional index (PNI) has been associated with outcome in metastatic breast cancer, but studies in CDK4/6 inhibitor-treated patients have used cohort-derived thresholds and examined only the pretreatment value. We assessed the PNI as a continuous variable, compared it with inflam...
E. Çoban, A. Kurt, Fırat Akagündüz et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.